Form D · Pharmaceuticals
Adamis Pharmaceuticals Corp
San Diego, CA · CIK 0000887247
Offering snapshot reported Jun 12, 2023 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2023 | Initial | $0 | No comparison | 12 | SEC filing |
| Jul 7, 2022 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Jun 30, 2020 | Initial | $590,000 | No comparison | 1 | SEC filing |
| Mar 6, 2020 | Initial | $6,090,000 | No comparison | 2 | SEC filing |
| Jul 11, 2013 | Initial | $6,502,158 | No comparison | 11 | SEC filing |
| Apr 24, 2013 | Initial | $575,000 | No comparison | 2 | SEC filing |
| Jul 9, 2012 | Initial | $1,000,000 | No comparison | 2 | SEC filing |
| Apr 6, 2012 | Initial | $3,299,920 | No comparison | 2 | SEC filing |
| Nov 23, 2010 | Initial | $0 | No comparison | 1 | SEC filing |
| May 31, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483973
Source: Form D, filed Jun 12, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard L. Aloi | Director, Executive |
| David C. Benedicto | Executive |
| Howard C. Birndorf | Director |
| Roshawn Blunt | Director |
| Dennis J Carlo | Director, Executive |
| Dennis J. Carlos | Director, Executive |
| Kenneth M Cohen | Director |
| Karen K Daniels | Executive |
| Meera J. Desai | Director |
| Robert O Hopkins | Executive |
| Craig A Johnson | Executive |
| David J. Marguglio | Executive |
| Thomas Moll | Executive |
| Ronald B. Moss | Executive |
| Tina S. Nova, Ph.D | Director |
| Tina S Nova, Ph. D. | Director |
| Vickie S. Reed | Director |
| Ebrahim Versi | Director, Executive |
| Jannine Versi | Director |
| Richard C. Williams | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
11682 El Camino Real Suite 300
San Diego, CA, 92130
San Diego, CA, 92130